HPV vaccine plan may hit smear test uptake

HPV vaccination for schoolgirls aged 12 and 13 will be introduced as early as autumn next year, after receiving the green light from the DoH.

But experts have stressed the importance of continuing the national cervical cancer-screening programme.

The DoH has accepted in principle the advice of the Joint Committee on Vaccination and Immunisation's HPV subgroup that the vaccine be introduced routinely for schoolgirls in the UK, subject to independent peer review of the cost-benefit analysis.

It is thought that a national immunisation programme could prevent 70 per cent of cases of cervical cancer.

Two candidate HPV vaccines are available. Gardasil is already on the market, while authorisation for Cervarix is expected before the end of the year.

Public health minister Caroline Flint said the benefits of introducing the vaccine would be felt by women and their families for generations to come.

But Ms Flint warned: 'A significant amount of planning is required before we can introduce the immunisation into our programme.'

Dr Sarah Jarvis, RCGP spokeswoman on women's health, said the introduction of the vaccine would increase GP's short-term workload but would mean fewer referrals in the long term for cervical cancer and other conditions such as genital warts.

'Even if the decision is made for community nurses to carry out the vaccination, GPs will still need to educate patients about it,' Dr Jarvis said.

'GPs will also have to work harder to encourage women to come in for their smear tests.'

Dr Jarvis stressed that it was important for cervical cytology services to continue despite the introduction of the vaccine, which only offers protection against HPV strains 16 and 18.

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Surrey GP practice targeted by aggressive anti-vaccination poster

Surrey GP practice targeted by aggressive anti-vaccination poster

Staff at a GP surgery in Surrey have been left completely demoralised after they...

JCVI issues final guidance on phase 2 of COVID-19 vaccination programme

JCVI issues final guidance on phase 2 of COVID-19 vaccination programme

The JCVI has confirmed the next phase of the COVID-19 vaccination programme will...

'Case-by-case' approach to GPs prescribing budesonide for COVID-19

'Case-by-case' approach to GPs prescribing budesonide for COVID-19

Inhaled budesonide is not expected to be routinely prescribed for patients receiving...

Coronavirus: Key guidance GPs need to know about COVID-19

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...

Over 45s offered COVID-19 jab as NHS completes vaccine offer to 32m priority patients

Over 45s offered COVID-19 jab as NHS completes vaccine offer to 32m priority patients

COVID-19 vaccination has been extended to patients aged 45-49 after the government...